In an axonal study of the squid AD model, it was filamentous rather than soluble forms of hyperphosphorylated tau that inhibited anterograde fast axonal transport through activating glycogen synthase kinase 3 (GSK3) and axonal protein phosphatase 1 (PP1) (Kanaan et al., 2011). The gene discussed is MAPT; the disease is Alzheimer disease.